PERSISTENCE RATE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)

被引：0
|
作者：
Lyu, R. [1 ]
Ding, Q. [2 ]
Govoni, M. [3 ]
Fan, T. [1 ]
机构：
[1] Merck & Co Inc, Whitehouse Stn, NJ USA
[2] Temple Univ, Philadelphia, PA 19122 USA
[3] Merck Sharp & Dohme Ltd, Rome, Italy
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS64
引用
收藏
页码：A384 / A384
页数：1
相关论文
共 50 条
  • [31] The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
    Furst, Daniel E.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (05) : 327 - 346
  • [32] COMPARISON OF REAL-WORLD PERSISTENCE OF SUBCUTANEOUSLY ADMINISTERED BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD) THERAPIES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (RA) SWITCHING FROM ANOTHER BIOLOGIC
    Best, Jennie H.
    Tominna, Lenore
    Abbass, Ibrahim
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1129 - 1129
  • [33] Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
    Fischer, Peter A.
    Rapoport, Ronald J.
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2018, 10 : 13 - 19
  • [34] Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
    Trang, D. A. M. Thuy
    Okamura, Koichi
    Suto, Takahito
    Sakane, Hideo
    Yonemoto, Yukio
    Nakajima, Takahito
    Tsushima, Yoshito
    Chikuda, Hirotaka
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [35] Onychocryptosis (ingrowing toe nail) in patients with rheumatoid arthritis on biologic therapies
    Davys, H. J.
    Woodburn, J.
    Bingham, S. J.
    Emery, P.
    RHEUMATOLOGY, 2006, 45 : I171 - I171
  • [36] Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
    D. A. M. Thuy Trang
    Koichi Okamura
    Takahito Suto
    Hideo Sakane
    Yukio Yonemoto
    Takahito Nakajima
    Yoshito Tsushima
    Hirotaka Chikuda
    Arthritis Research & Therapy, 23
  • [37] Increased incidence of infection in rheumatoid arthritis patients treated with biologic therapies
    Rachel Murphy
    Nature Clinical Practice Rheumatology, 2006, 2 (2): : 60 - 60
  • [38] Persistence and adherence to biologic therapies in juvenile idiopathic arthritis
    Nieto-Gonzalez, Juan Carlos
    Trives-Folguera, Laura
    Melgarejo-Ortuno, Alejandra
    Ais, Aranzazu
    Serrano-Benavente, Belen
    Sanjurjo, Maria
    Alvaro-Gracia, Jose Maria
    Saez, Indalecio Monteagudo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [39] Persistence and adherence to biologic therapies in juvenile idiopathic arthritis
    Juan Carlos Nieto-González
    Laura Trives-Folguera
    Alejandra Melgarejo-Ortuño
    Aranzazu Ais
    Belén Serrano-Benavente
    María Sanjurjo
    José María Álvaro-Gracia
    Indalecio Monteagudo Sáez
    Scientific Reports, 11
  • [40] LABOR IMPACT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) TREATED WITH ADVANCED THERAPIES
    Silva, L.
    Balsa, A.
    Sanmarti, R.
    Valderrama, M.
    De Lossada Juste, A.
    Rejas, J.
    Ruiz, M. A.
    Montoro, M.
    VALUE IN HEALTH, 2023, 26 (12) : S519 - S519
12345